Ligand validation:6SGP

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6SGP_NAG_A_809	59%	54%	0.108	0.89	0.61	1.17	-	1	1	0	100%	0.9333
4MCQ_NAG_A_811	89%	47%	0.064	0.941	0.67	1.37	-	2	0	0	100%	0.9333
4MCR_NAG_A_811	87%	56%	0.068	0.939	0.55	1.12	-	1	1	0	100%	0.9333
4LQG_NAG_A_814	86%	42%	0.071	0.939	0.87	1.37	-	3	1	0	100%	0.9333
8BO8_NAG_A_806	82%	44%	0.067	0.922	0.77	1.36	-	3	1	0	100%	0.9333
4JYW_NAG_A_813	76%	57%	0.087	0.923	0.75	0.9	-	-	1	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.